A comparative kinetic study of ivermectin and moxidectin in lactating camels (Camelus dromedarius)

被引:39
作者
Oukessou, M
Berrag, B
Alvinerie, M
机构
[1] Inst Agron & Vet Hassan II, Dept Physiol & Therapeut, Rabat, Morocco
[2] Inst Agron & Vet Hassan II, Dept Parasitol, Rabat, Morocco
[3] INRA, Stn Pharmacol & Toxicol, F-31931 Toulouse, France
关键词
ivermectin; moxidectin; endectocide agents; kinetics; camel; milk;
D O I
10.1016/S0304-4017(99)00045-X
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The plasma and milk kinetics of ivermectin (IVM) and moxidectin (MXD) was evaluated in lactating camels treated subcutaneously (0.2 mg kg(-1))with commercially available formulations for cattle. Blood and milk samples were taken concurrently at predetermined times from 12 h up to 60 days post-administration. No differences were observed between plasma and milk kinetics of IVM, while substantial differences were noted between plasma and milk profiles of MXD in that both the maximal concentration (C-max) and the area under concentrations curves (AUC) were three to four-fold higher for milk than for plasma. The time (T-max) to reach C-max was significantly faster for MXD (1.0 day) than that for IVM (12.33 days). The C-max and the AUC were significantly higher for MXD (C-max = 8.33 ng ml(-1); AUC = 70.63 ng day ml(-1)) than for IVM (C-max = 1.79 ng ml(-1); AUC = 30.12 ng day ml(-1)) respectively. Drug appearance in milk was also more rapid for MXD (T-max = 3.66 days) compared to IVM (T-max = 17.33 days). The extent of drug exchange from blood to milk, expressed by the AUC(milk)/AUC(plasma) ratio, was more than three-fold greater for MXD (4.10) compared to that of TVM (1.26), which is consistent with the more lipophilic characteristic of MXD. However, the mean residence time (MRT) was similar in both plasma and milk for each drug. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 28 条
[1]   Pharmacokinetic considerations in the camel (Camelus dromedarius): A review [J].
Ali, BH ;
Oukessou, M ;
Bashir, AK .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 1996, 115 (01) :1-9
[2]  
Alvinerie M, 1998, VET RES, V29, P113
[3]  
ALVINERIE M, 1993, VET RES, V24, P417
[4]  
Alvinerie M, 1996, VET RES, V27, P545
[5]   PHARMACOKINETICS AND TEMPERATURE [J].
BALLARD, BE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (09) :1345-1358
[6]  
BOGAN JA, 1988, J VET PHARMACOL THER, V11, P260, DOI 10.1111/j.1365-2885.1988.tb00151.x
[7]  
BOYCE W, 1984, J AM VET MED ASSOC, V185, P1307
[8]   LIQUID-CHROMATOGRAPHIC DETERMINATION OF IVERMECTIN IN ANIMAL PLASMA WITH TRIFLUOROACETIC-ANHYDRIDE AND N-METHYLIMIDAZOLE AS THE DERIVATIZATION REAGENT [J].
DEMONTIGNY, P ;
SHIM, JSK ;
PIVNICHNY, JV .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (06) :507-511
[9]   BODY-COMPOSITION CHANGES IN GOATS DURING EARLY LACTATION ESTIMATED USING A 2-POOL MODEL OF TRITIATED-WATER KINETICS [J].
DUNSHEA, FR ;
BELL, AW ;
TRIGG, TE .
BRITISH JOURNAL OF NUTRITION, 1990, 64 (01) :121-131
[10]   Comparison of the persistent activity of ivermectin, abamectin, doramectin and moxidectin in cattle [J].
Entrocasso, C ;
Parra, D ;
Vottero, D ;
Farias, M ;
Uribe, LF ;
Ryan, WG .
VETERINARY RECORD, 1996, 138 (04) :91-92